Sarepta Therapeutics said Tuesday that a 16-year-old boy died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy, the first known death linked to the treatment. The teenager … [+589 chars]Read More
Teenager who received Elevidys Sareptas Duchenne gene therapy dies STAT
